Teva Pharmaceutical to pay $519 million to resolve FCPA allegations
A Russian subsidiary of the Israel-based drug manufacturer agreed to plead guilty to participating in a $65 million bribe scheme in Russia, while the parent company will enter into a three-year deferred prosecution agreement.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10